0001144204-19-045932.txt : 20190925 0001144204-19-045932.hdr.sgml : 20190925 20190925170532 ACCESSION NUMBER: 0001144204-19-045932 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190925 DATE AS OF CHANGE: 20190925 EFFECTIVENESS DATE: 20190925 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AquaMed Technologies, Inc. CENTRAL INDEX KEY: 0001468929 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 264042544 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-349643 FILM NUMBER: 191114839 BUSINESS ADDRESS: STREET 1: 2150 CABOT BLVD WEST, STREET 2: SUITE B CITY: LANGHORNE STATE: PA ZIP: 19047 BUSINESS PHONE: 215 702-8550 MAIL ADDRESS: STREET 1: 2150 CABOT BLVD WEST, STREET 2: SUITE B CITY: LANGHORNE STATE: PA ZIP: 19047 D 1 primary_doc.xml X0708 D LIVE 0001468929 AquaMed Technologies, Inc. 2150 CABOT BOULEVARD, WEST SUITE B LANGHORNE PA PENNSYLVANIA 19067 (215) 702-8550 DELAWARE None None Corporation true Adam R. Levy 2150 Cabot Boulevard, West Suite B Langhorne PA PENNSYLVANIA 19067 Executive Officer Chief Executive Officer and President Joe Williams 2150 Cabot Boulevard, West Suite B Langhorne PA PENNSYLVANIA 19067 Executive Officer Interim Chief Financial Officer David Stefansky 2150 Cabot Boulevard, West Suite B Langhorne PA PENNSYLVANIA 19067 Director Nachum Stein 2150 Cabot Boulevard, West Suite B Langhorne PA PENNSYLVANIA 19067 Director Biotechnology Decline to Disclose 06b false 2019-09-10 false true false 0 Alere Financial Partners, A Division of Cova Capital Partners, LLC 109761 None None 6851 JERICHO TPKE SUITE 205 SYOSSET NY NEW YORK 11791 NY NEW YORK false 750000 175000 575000 false 2 45000 true 0 Alere served as the placement agent and is entitled to receive a fee equal to 6% of the total gross proceeds and warrants to purchase shares of common stock equal to 10% of the number of shares issued to the investors in the private placement. 0 The Issuer intends to use the net proceeds for general corporate purposes. false AquaMed Technologies, Inc. /s/ Adam R. Levy Adam R. Levy Chief Executive Officer and President 2019-09-25